Repligen News - RGEN

Company Name	Stock Ticker Symbol	Market	Type
Repligen Corp	RGEN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-2.60	-1.61%	159.27	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
160.48	158.33	164.71	159.27	161.87

more quote information »

Recent News

Date	Time	Source	Heading
12/07/2023	07:39	EDGAR2	Form 8-K - Current report
12/07/2023	07:30	GLOBE	Repligen Announces Private Convertible Transaction of $600..
11/16/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/14/2023	14:01	GLOBE	UPDATE – Repligen Announces Publication of the Company’s..
11/14/2023	07:30	GLOBE	Repligen Announces Publication of the Company’s 2022..
11/13/2023	17:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	11:56	EDGAR2	Form 144 - Report of proposed sale of securities
11/07/2023	07:30	GLOBE	Repligen Corporation to Present at Upcoming Investor..
11/02/2023	07:30	GLOBE	Repligen Launches TangenX® SC as First-to-Market Holder-Free..
10/31/2023	16:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/2023	07:48	EDGAR2	Form 8-K - Current report
10/31/2023	07:30	GLOBE	Repligen Reports Third Quarter 2023 Financial Results and..
10/17/2023	07:30	GLOBE	Repligen to Report Third Quarter 2023 Financial Results
10/03/2023	20:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	20:03	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/02/2023	07:42	EDGAR2	Form 8-K - Current report
10/02/2023	07:30	GLOBE	Repligen Appoints Olivier Loeillot as President and Chief..
9/27/2023	17:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/27/2023	17:22	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/26/2023	07:44	EDGAR2	Form 8-K - Current report
9/26/2023	07:30	GLOBE	Repligen Announces Agreement to Acquire Fluid Management..
9/12/2023	09:20	EDGAR2	Form 8-K - Current report
9/12/2023	07:30	GLOBE	Repligen Appoints Jason K. Garland as Chief Financial..
9/01/2023	07:30	GLOBE	Repligen Corporation to Present at Wells Fargo Healthcare..
8/30/2023	16:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/29/2023	14:04	EDGAR2	Form 144 - Report of proposed sale of securities
8/17/2023	08:00	GLOBE	Sartorius and Repligen Corporation Launch Integrated System..
8/02/2023	16:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/2023	07:54	EDGAR2	Form 8-K - Current report
8/02/2023	07:30	GLOBE	Repligen Reports Second Quarter 2023 Financial Results and..
7/19/2023	07:30	GLOBE	Repligen to Report Second Quarter 2023 Financial Results
5/02/2023	07:30	GLOBE	Repligen Reports First Quarter 2023 Financial Results and..
4/18/2023	07:30	GLOBE	Repligen to Report First Quarter 2023 Financial Results
3/14/2023	07:30	GLOBE	Repligen Corporation to Present at KeyBanc Life Science and..
2/22/2023	07:30	GLOBE	Repligen Reports Fourth Quarter and Full Year 2022 Financial..
2/09/2023	07:30	GLOBE	Repligen Appoints Martin D. Madaus to Board of Directors
2/08/2023	07:30	GLOBE	Repligen to Report Fourth Quarter and Full Year 2022..
1/03/2023	07:30	GLOBE	Repligen Corporation to Present at 41st Annual J.P. Morgan..